These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Enoxacin pharmacokinetics and efficacy in CF-1 mice. Chartrand SA; Scribner RK; Marks MI; Dice J J Antimicrob Chemother; 1987 Feb; 19(2):221-4. PubMed ID: 3553134 [TBL] [Abstract][Full Text] [Related]
6. Microbiologic, Pharmacokinetic, and Clinical Effects of Corneal Collagen Cross-Linking on Experimentally Induced Pseudomonas Keratitis in Rabbits. Cosar CB; Kucuk M; Celik E; Gonen T; Akyar I; Serteser M; Tokat F; Ince U Cornea; 2015 Oct; 34(10):1276-80. PubMed ID: 26226468 [TBL] [Abstract][Full Text] [Related]
7. Povidone-iodine (betadine) in the treatment of experimental Pseudomonas aeruginosa keratitis. Michalová K; Moyes AL; Cameron S; Juni BA; Obritsch WF; Dvorak JA; Doughman DJ; Rhame FS Cornea; 1996 Sep; 15(5):533-6. PubMed ID: 8862931 [TBL] [Abstract][Full Text] [Related]
8. Comparison of ophthalmic gatifloxacin 0.3% and ciprofloxacin 0.3% in healing of corneal ulcers associated with Pseudomonas aeruginosa-induced ulcerative keratitis in rabbits. Jensen H; Zerouala C; Carrier M; Short B J Ocul Pharmacol Ther; 2005 Feb; 21(1):36-43. PubMed ID: 15718826 [TBL] [Abstract][Full Text] [Related]
9. Treatment of bacterial ulcers of the cornea in the rabbit: a comparison of administration by eye drops and subconjunctival injections. Baum J Trans Am Ophthalmol Soc; 1982; 80():369-90. PubMed ID: 6763800 [TBL] [Abstract][Full Text] [Related]
10. Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitis. Sanders ME; Moore QC; Norcross EW; Sanfilippo CM; Hesje CK; Shafiee A; Marquart ME Cornea; 2011 Jan; 30(1):83-90. PubMed ID: 20847656 [TBL] [Abstract][Full Text] [Related]
11. Topical ciprofloxacin treatment of Pseudomonas keratitis in rabbits. O'Brien TP; Sawusch MR; Dick JD; Gottsch JD Arch Ophthalmol; 1988 Oct; 106(10):1444-6. PubMed ID: 3140772 [TBL] [Abstract][Full Text] [Related]
13. Use of enoxacin in a patient with cystic fibrosis. Miller MG; Ghoneim AT; Littlewood JM Lancet; 1985 Mar; 1(8429):646. PubMed ID: 2857989 [No Abstract] [Full Text] [Related]
14. Oral enoxacin used to cure spinal osteomyelitis due to aminoglycoside-resistant Pseudomonas aeruginosa. Bailey RR; Newman E N Z Med J; 1985 Jun; 98(781):508. PubMed ID: 3859782 [No Abstract] [Full Text] [Related]
15. Application of topical lomefloxacin against experimental Pseudomonas endophthalmitis in rabbits. Hatano H; Inoue K; Shia S; Liping W Acta Ophthalmol (Copenh); 1993 Oct; 71(5):666-70. PubMed ID: 8109214 [TBL] [Abstract][Full Text] [Related]
16. Zymar (Gatifloxacin 0.3%) shows excellent Gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White rabbit keratitis model. Mah FS; Romanowski EG; Kowalski RP; Yates KA; Gordon YJ Cornea; 2007 Jun; 26(5):585-8. PubMed ID: 17525656 [TBL] [Abstract][Full Text] [Related]
17. Gentamicin penetration in the aqueous humor of eyes with corneal ulcers. Sloan SH; Pettit TH; Litwack KD Am J Ophthalmol; 1972 May; 73(5):750-3. PubMed ID: 4623935 [No Abstract] [Full Text] [Related]
18. [Therapy of bacterial corneal diseases]. Heimann K Ber Zusammenkunft Dtsch Ophthalmol Ges; 1972; 71():260-5. PubMed ID: 4679322 [No Abstract] [Full Text] [Related]